VLPNPV 2022 - Virus-Like Particle & Nano-Particle Vaccines

Topics

• VLP Vaccine Manufacturing
• Virus-Like Particle Vaccines
• VLP Platforms as Delivery Systems for Therapeutics, Imaging and Antigen Presentation
• Nano-Particles and Nano-Particulate Vaccines
• Formulation and Stability of VLP and Nano-Particulate Vaccines and Adjuvants
• Structure (non-enveloped, enveloped and synthetic)
• VLP Expression Systems (Baculovirus, Cell Culture, Yeast, Plants)
• Delivery Systems (including Microneedles)
• HepB
• Safety and Regulatory Issues (regulation of expression systems)
• Influenza
• HPV
• Clinical Trials Updates
• Developing VLP Candidates
• Chitosan Particles
• ISCOMs & ISCOMATRIX
• VLPs as Protein Delivery Systems
• Liposomes
• Novel Applications (eg Cell-Free Synthesis)
• VLPs for Drug Delivery
• Particulate-Based Vaccines
• Nanotechnology Approaches (Non-Conventional VLPs)

Who should Attend

Researchers/contributors from academic programmes, industrial, governmental and regulatory groups.